University of Miami Researchers Receive $2.9 Million to Study IBD Genetics in Hispanic Population
February 3rd 2023Research by Maria T. Abreu, M.D., and Jacob McCauley, Ph.D., should help fill a gap in the research of the genetics of inflammatory bowel disease, including ulcerative colitis.
Read More
For Ulcerative Colitis, Two First-In-Class Candidates and an Interleukin-23 Competition
February 1st 2023A Swedish and a French company have treatments with novel mechanisms of action in late-stage development. Meanwhile, AbbVie, Janssen and Eli Lilly are vying to get the first interleukin-23 inhibitor for ulcerative colitis on the market.
Read More